• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重组沙门氏菌载体递送3M2e-铁蛋白融合纳米颗粒可提供针对H9N2和H7N9禽流感病毒的交叉保护。

Recombinant Salmonella vector delivery 3M2e-ferritin fusion nanoparticles provide cross protection against H9N2 and H7N9 avian influenza viruses.

作者信息

Sun Wangyangji, Li Yu-An, Li Zewei, Li Guohui, Du Yuanzhao, Shi Huoying

机构信息

College of Veterinary Medicine, Yangzhou University, Yangzhou, Jiangsu 225009, China; Jiangsu Co-Innovation Center for the Prevention and Control of Important Animal Infectious Diseases and Zoonoses, Yangzhou, China.

College of Veterinary Medicine, Yangzhou University, Yangzhou, Jiangsu 225009, China; Jiangsu Co-Innovation Center for the Prevention and Control of Important Animal Infectious Diseases and Zoonoses, Yangzhou, China.

出版信息

Vet Microbiol. 2025 Jun;305:110546. doi: 10.1016/j.vetmic.2025.110546. Epub 2025 May 5.

DOI:10.1016/j.vetmic.2025.110546
PMID:40339259
Abstract

In recent years, the advancement of nanomedicine has revolutionized the field of vaccine development. Numerous nanoparticle-based nano vaccine candidates have been continuously developed. Herein, we describe a universal avian influenza virus (AIV) vaccine candidate based on ferritin self-assembling nanoparticles (NPs). The ferritin fused with 3M2e was delivered by an recombinant Salmonella vector, resulting in the formation of a novel recombinant strain, rSC0130(pYA3342-3M2eNPs). The 3M2e-ferritin fusion protein was efficiently expressed and self-assembled into NPs within the recombinant strain. The delivery of the recombinant strain rSC0130(pYA3342-3M2eNPs), which carries the 3M2e-ferritin fusion NPs, induced robust specific cellular and humoral immune responses against AIV in vivo, ultimately providing chickens with effective cross-protection against challenges from H9N2 and H7N9 avian influenza viruses. Our study underscores the potential of the Salmonella platform for delivering protein-based NPs and offers new insights into the development of universal vaccines for AIVs.

摘要

近年来,纳米医学的进展彻底改变了疫苗开发领域。众多基于纳米颗粒的纳米疫苗候选物不断被研发出来。在此,我们描述了一种基于铁蛋白自组装纳米颗粒(NPs)的通用型禽流感病毒(AIV)疫苗候选物。与3M2e融合的铁蛋白由重组沙门氏菌载体递送,从而形成一种新型重组菌株rSC0130(pYA3342 - 3M2eNPs)。3M2e - 铁蛋白融合蛋白在重组菌株内高效表达并自组装成纳米颗粒。携带3M2e - 铁蛋白融合纳米颗粒的重组菌株rSC0130(pYA3342 - 3M2eNPs)的递送在体内诱导了针对AIV的强大特异性细胞免疫和体液免疫反应,最终为鸡提供了针对H9N2和H7N9禽流感病毒攻击的有效交叉保护。我们的研究强调了沙门氏菌平台递送基于蛋白质的纳米颗粒的潜力,并为AIV通用疫苗的开发提供了新的见解。

相似文献

1
Recombinant Salmonella vector delivery 3M2e-ferritin fusion nanoparticles provide cross protection against H9N2 and H7N9 avian influenza viruses.重组沙门氏菌载体递送3M2e-铁蛋白融合纳米颗粒可提供针对H9N2和H7N9禽流感病毒的交叉保护。
Vet Microbiol. 2025 Jun;305:110546. doi: 10.1016/j.vetmic.2025.110546. Epub 2025 May 5.
2
Delivery of dendritic cells targeting 3M2e-HA2 nanoparticles with a CpG adjuvant via lysosomal escape of Salmonella enhances protection against H9N2 avian influenza virus.通过沙门氏菌的溶酶体逃逸递送靶向3M2e-HA2纳米颗粒并带有CpG佐剂的树突状细胞可增强对H9N2禽流感病毒的保护作用。
Poult Sci. 2025 Jan;104(1):104616. doi: 10.1016/j.psj.2024.104616. Epub 2024 Dec 1.
3
Enhancement of protective efficacy of recombinant attenuated Salmonella typhimurium delivering H9N2 avian influenza virus hemagglutinins(HA) antigen vaccine candidate strains by C-C motif chemokine ligand 5 in chickens(chCCL5).鸡 C-C 基序趋化因子配体 5(chCCL5)增强表达 H9N2 禽流感病毒血凝素(HA)抗原疫苗候选株的重组减毒鼠伤寒沙门氏菌的保护效力。
Vet Microbiol. 2024 Nov;298:110264. doi: 10.1016/j.vetmic.2024.110264. Epub 2024 Oct 9.
4
Vaccination with recombinant 4 × M2e.HSP70c fusion protein as a universal vaccine candidate enhances both humoral and cell-mediated immune responses and decreases viral shedding against experimental challenge of H9N2 influenza in chickens.用重组4×M2e.HSP70c融合蛋白作为通用疫苗候选物进行疫苗接种,可增强体液免疫和细胞介导的免疫反应,并减少鸡在H9N2流感实验性攻毒后的病毒排泄。
Vet Microbiol. 2014 Nov 7;174(1-2):116-26. doi: 10.1016/j.vetmic.2014.09.009. Epub 2014 Sep 23.
5
Vaccine Efficacy of Inactivated, Chimeric Hemagglutinin H9/H5N2 Avian Influenza Virus and Its Suitability for the Marker Vaccine Strategy.灭活嵌合血凝素H9/H5N2禽流感病毒的疫苗效力及其对标记疫苗策略的适用性
J Virol. 2017 Feb 28;91(6). doi: 10.1128/JVI.01693-16. Print 2017 Mar 15.
6
Recombinant Marek's disease virus type 1 provides full protection against H9N2 influenza A virus in chickens.重组马立克氏病病毒 1 型可完全保护鸡抵抗 H9N2 流感病毒。
Vet Microbiol. 2024 Nov;298:110242. doi: 10.1016/j.vetmic.2024.110242. Epub 2024 Sep 2.
7
Development of an Inactivated H7N9 Subtype Avian Influenza Serological DIVA Vaccine Using the Chimeric HA Epitope Approach.基于嵌合 HA 表位策略研制 H7N9 亚型禽流感病毒灭活血清学区分疫苗
Microbiol Spectr. 2021 Oct 31;9(2):e0068721. doi: 10.1128/Spectrum.00687-21. Epub 2021 Sep 29.
8
Adjuvant-free, self-assembling ferritin nanoparticle vaccine coupled with influenza virus hemagglutinin protein carrying M1 and PADRE epitopes elicits cross-protective immune responses.不含佐剂、自组装的铁蛋白纳米颗粒疫苗与携带M1和PADRE表位的流感病毒血凝素蛋白偶联,可引发交叉保护性免疫反应。
Front Immunol. 2025 Jan 31;16:1519866. doi: 10.3389/fimmu.2025.1519866. eCollection 2025.
9
Immunogenicity and Protective Potential of Mucosal Vaccine Formulations Based on Conserved Epitopes of Influenza A Viruses Fused to an Innovative Ring Nanoplatform in Mice and Chickens.基于融合到创新环纳米平台的流感 A 病毒保守表位的黏膜疫苗制剂在小鼠和鸡中的免疫原性和保护潜力。
Front Immunol. 2021 Nov 11;12:772550. doi: 10.3389/fimmu.2021.772550. eCollection 2021.
10
Self-assembling nanoparticle vaccine elicits a robust protective immune response against avian influenza H5N6 virus in chickens.自组装纳米颗粒疫苗在鸡体内引发针对禽流感H5N6病毒的强大保护性免疫反应。
Int J Biol Macromol. 2025 Jan;287:138405. doi: 10.1016/j.ijbiomac.2024.138405. Epub 2024 Dec 4.